MHRA (UK) · Jun 8, 2026
Decision: Medical devices given exceptional use authorisations
List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled.
Global Health · page 2
UK, EU & international health agencies
DHSC (UK) · Jun 8, 2026
Research: Skin cancer risks from sunbed use and their control
COMARE’s 21st report reviews scientific evidence on skin cancer risks and other health effects from sunbed use and considers options for control of their use.
NHS England · Jun 7, 2026
500,000 NHS staff to get new artificial intelligence tools to help free up more time for patients
More than half a million NHS staff are being given access to new artificial intelligence (AI) tools that could free up an average of 2 days every month from admin duties, freeing up more time for the duties that matter most for patients and staff. NHS England announced today that it is significantly accelerating AI […]
MHRA (UK) · Jun 5, 2026
Decision: Human and veterinary medicines: register of licensed manufacturing sites
The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only.
MHRA (UK) · Jun 5, 2026
Notice: Register of brokers authorised to deal in human medicines
Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.
MHRA (UK) · Jun 5, 2026
Decision: Medicines: new manufacturing and wholesale dealer licences
List of sites granted a manufacturer or wholesale dealer licence.
MHRA (UK) · Jun 5, 2026
Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
MHRA (UK) · Jun 5, 2026
Decision: Human medicines: register of licensed wholesale distribution sites
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human).
MHRA (UK) · Jun 5, 2026
MHRA review of the benefits and risks of avacopan
Avacopan is used in the treatment of some rare autoimmune diseases affecting small blood vessels.
DHSC (UK) · Jun 5, 2026
Guidance: DHSC public appointments: 2026 to 2027
Non-executive appointments to the Department of Health and Social Care's public bodies and committees from April 2026 to March 2027.
DHSC (UK) · Jun 5, 2026
Research: Housing and health in local strategic health planning
Findings from a national review of how housing features in local strategic health planning documents in England.
MHRA (UK) · Jun 5, 2026
Field Safety Notices: 18 -22 May 2026
List of Field Safety Notices for 18 -22 May 2026
DHSC (UK) · Jun 5, 2026
Local areas prepare new Experts at Hand teams
Local areas to begin increasing access to speech and language therapists, occupational therapists and educational psychologists from September 2026
UKHSA (UK) · Jun 5, 2026
Guidance: Vaccination of individuals with uncertain or incomplete immunisation
One-page summary for health professionals and immunisation practitioners giving vaccinations.
UKHSA (UK) · Jun 5, 2026
Hantaviruses
The characteristics, diagnosis, epidemiology of hantaviruses.
UKHSA (UK) · Jun 4, 2026
Research: Outbreaks under monitoring in 2026
Latest information on global disease events under monitoring.
UKHSA (UK) · Jun 4, 2026
Guidance: NRRW: employment and follow-up information
Employers provide records of employment episodes, occupational exposure to ionising radiation and some personal identifying data.
UKHSA (UK) · Jun 4, 2026
Guidance: MenB vaccine and paracetamol
Information about the meningococcal B (MenB) vaccine and paracetamol use.
MHRA (UK) · Jun 4, 2026
Adjuvanted trivalent influenza vaccine authorised for adults aged 50 and over
The adjuvanted trivalent influenza vaccine works by stimulating the immune system to produce its own protection against flu.
MHRA (UK) · Jun 4, 2026
Research: MHRA Public Sector Equality Duty Report 2025-2026
MHRA’s Public Sector Equality Duty report 2026 sets out progress on equality, diversity and inclusion across regulation, public engagement and workforce.
UKHSA (UK) · Jun 4, 2026
Research: Notifiable diseases: causative agents reports for 2026
Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses (see important note in Details section, below).
UKHSA (UK) · Jun 4, 2026
Guidance: Influenza, COVID-19 and other respiratory viruses: sources of surveillance data
Sources of data for the surveillance systems used to monitor COVID-19, influenza and other seasonal respiratory viruses in England.
UKHSA (UK) · Jun 4, 2026
Research: GP out-of-hours syndromic surveillance: weekly bulletins for 2026
The number of people contacting their GPs outside of surgery hours under the syndromic surveillance system.
UKHSA (UK) · Jun 4, 2026
Research: Syndromic surveillance: weekly summaries for 2026
This weekly summary highlights changes in the number of people visiting GPs, going to emergency departments and calling NHS 111.